1h Free Analyst Time
Impax Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.Speak directly to the analyst to clarify any post sales queries you may have.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Summarization of the company’s business strategy.
- SWOT analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
Highlights
Impax Laboratories Inc (Impax) develops, manufactures and markets generic and branded pharmaceuticals. It offers solid dose and alternative dosage form generic drugs in a broad range of therapeutic areas; and proprietary branded pharmaceutical products for the treatment of central nervous system (CNS) disorders and other select specialties. Impax develops several controlled-release delivery technologies which can be utilized with a variety of oral dosage forms and drugs. It has manufacturing facilities in Hayward, California; Middlesex, New Jersey; and in Taiwan. The company sells its products directly to wholesalers and large retail drug chains and through unrelated third-party pharmaceutical entities. Impax is headquartered in Hayward, California, the US.
Impax Laboratories Inc Key Recent Developments
Mar 01, 2018: Impax Reports Fourth Quarter and Full Year 2017 Results
Nov 09, 2017: Impax Reports Third Quarter 2017 Results
Nov 08, 2017: Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly
Aug 09, 2017: Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million
May 10, 2017: Impax Reports First Quarter 2017 Financial Results
Reasons to buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with this detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Section 1 - About the Company- Impax Laboratories Inc - Key Facts
- Impax Laboratories Inc - Key Employees
- Impax Laboratories Inc - Key Employee Biographies
- Impax Laboratories Inc - Major Products and Services
- Impax Laboratories Inc - History
- Impax Laboratories Inc - Company Statement
- Impax Laboratories Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Section 2 - Company Analysis
- Company Overview
- Impax Laboratories Inc - Business Description
- Business Segment: Impax Generics
- Overview
- Performance
- Business Segment: Impax Specialty Pharma
- Overview
- Performance
- R&D Overview
- Impax Laboratories Inc - SWOT Analysis
- SWOT Analysis - Overview
- Impax Laboratories Inc - Strengths
- Impax Laboratories Inc - Weaknesses
- Impax Laboratories Inc - Opportunities
- Impax Laboratories Inc - Threats
- Impax Laboratories Inc - Key Competitors
Section 3 - Company’s Lifesciences Financial Deals and Alliances
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
- Impax Laboratories Inc, Recent Deals Summary
Section 4 - Company’s Recent Developments
- Mar 01, 2018: Impax Reports Fourth Quarter and Full Year 2017 Results
- Nov 09, 2017: Impax Reports Third Quarter 2017 Results
- Nov 08, 2017: Impax Laboratories Mourns the Passing of Board Member Richard A. Bierly
- Aug 09, 2017: Impax Reports Solid Second Quarter 2017 Results with Total Revenues Increasing 17% to $202 Million
- May 10, 2017: Impax Reports First Quarter 2017 Financial Results
- Mar 27, 2017: Impax Board of Directors Appoints Paul M. Bisaro President and CEO
- Mar 01, 2017: Impax Reports Fourth Quarter and Full Year 2016 Financial Results
Section 5 - Appendix
- Methodology
- About
- Contact
- Disclaimer
List of Tables
- Impax Laboratories Inc, Key Facts
- Impax Laboratories Inc, Key Employees
- Impax Laboratories Inc, Key Employee Biographies
- Impax Laboratories Inc, Major Products and Services
- Impax Laboratories Inc, History
- Impax Laboratories Inc, Other Locations
- Impax Laboratories Inc, Subsidiaries
- Impax Laboratories Inc, Key Competitors
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
- Impax Laboratories Inc, Recent Deals Summary
List of Figures
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
- Impax Laboratories Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Companies Mentioned
A selection of companies mentioned in this report includes:
- Teva Pharmaceutical Industries Ltd
- Sun Pharmaceutical Industries Ltd
- Par Pharmaceutical Holdings Inc
- Mylan NV
- Lupin Pharmaceuticals Inc
- Lannett Company Inc
- Avanir Pharmaceuticals Inc
- Allergan Plc
